A University of California, Davis (UC Davis) employed at the UC Davis Comprehensive Cancer Center received $600,000 from a Susan G. Komen® grant to develop artificial intelligence (AI) models to predict cancer risk at the personalized level, part of a movement toward more precision-based treatment regimens. Part of a larger $14 million program supporting leading researchers focused on breast cancer, Department of Radiology Chair Elizabeth Morris will work on advancing UC Davis’ contribution to personalized medicine. This is an important endeavor that could save many lives as 1 in 8 women in the U.S. alone (13%) will develop invasive breast cancer in the course of a lifetime.
The grant is included in the $14 million that Komen was recently awarded. The funds support the organization’s mission to end breast cancer through funding two key focus areas: research to better detect and treat stage IV (metastatic) breast cancer and research to eliminate disparities in breast cancer outcomes.
Honored and Ready to Work
Dr. Morris went on the record recently in a UC Davis press release, “I’m honored to receive this important grant to advance our artificial intelligence ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).